S. Barrett

发表

Microbial epidemiology and clinical risk factors of carbapenemase-producing Enterobacterales amongst Irish patients from first detection in 2009 until 2020

B. Slevin, J. Powell, L. Power, 2022, Infection prevention in practice.

Association of Blood Products Administration During Cardiopulmonary Bypass and Excessive Post-operative Bleeding in Pediatric Cardiac Surgery

D. Bichell, B. Donahue, B. Saville, 2015, Pediatric Cardiology.

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

E. Hadley, K. Hood, B. Jani, 2022, SSRN Electronic Journal.

Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort

M. Nelson, Yufeng Shen, P. Demoly, 2020, The Journal of allergy and clinical immunology.

Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions

A. Morris, M. Daly, M. Nelson, 2019, Clinical pharmacology and therapeutics.

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Nigel de Kare-Silver, S. Royal, K. Hood, 2022, The Lancet.

The practice of polypharmacy involving herbal and prescription medicines in the treatment of diabetes mellitus, hypertension and gastrointestinal disorders in Jamaica.

N. Younger, N. Clarke, R. Delgoda, 2004, The West Indian medical journal.

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Thanh T. Tran, Dung T. Nguyen, D. Blacker, 2020, The Lancet Neurology.

IMPACT-Global Hip Fracture Audit: Nosocomial infection, risk prediction and prognostication, minimum reporting standards and global collaborative audit

Ashutosh Kumar Singh, N. Clement, A. MacLullich, 2022, The Surgeon.

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

K. Hood, B. Jani, S. Khoo, 2023, BMJ open.